The new regulatory clearance from the American Food and Drug Administration, FDA, concerns the SyMRI NEURO product package. Combined with FDA's clearance from August 2017, this means SyMRI as a whole can now be offered to clinics and hospitals on the US market.

ImageGuideEcho—the first registry devoted solely to measuring quality in cardiovascular ultrasounds— is now open to U.S. physicians.

New joint guidelines from the American Heart Association and American Stroke Association (AHA/ASA) may now allow more patients to be eligible for acute ischemic stroke (AIS) procedures and post-treatment medications, including brain-imaging treatment.

A new method to capture images of the biomechanical properties of the heart may soon be a technique used to heal heart attack victims.

Mastering the art of balancing risks and benefits, according to Matthew Davenport, MD, from the University of Michigan, is what medicine is all about. When anecdotes about gadolinium-based contrast media agents allegedly poisoning patients became increasingly mainstream, its use in imaging procedures like MRIs has been heavily questioned by the medical community.  

According to a recent article by Cardiovascular Business (CVB), a new study published by the Journal of American College of Cardiology demonstrated that whole-body molecular imaging can identify a shared inflammatory response between the cardiovascular and central nervous systems following myocardial infarction (MI).  

A 61-year-old Army veteran has recently experienced an unsettling, real-life game of "Operation" which has turned into a legal battle with the U.S.  

Cardiologists are receiving more exposure to different imaging modalities during their fellowships, but their job prospects and training vary widely. A more comprehensive and multimodality training approach could lead to better results.